MedPath

Evaluation of D-chiro-inositol Treatments

Not Applicable
Completed
Conditions
Inositol
Ovulation
Asprosin
Testosterone
Insulin
Interventions
Dietary Supplement: D-chiro-inositol
Registration Number
NCT05448378
Lead Sponsor
Lo.Li.Pharma s.r.l
Brief Summary

Healthy women will take tablets containing 600 mg D-chiro-inositol twice per day for one month. We will evaluate metabolic and hormonal.parameters, as insulienmia, glycemia, estradiol, testosterone.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
10
Inclusion Criteria
  • Good state of health;
  • Regular menstrual cycle.
Exclusion Criteria
  • pregnancy;
  • delivery in the previous 6 months;
  • currently breastfeeding;
  • menopause;
  • alcohol or drug abuse;
  • insulin resistance defined as HOMA-IR index greater than or equal to 2.5;
  • other medical morbidities, such as hypertension, PCOS, or diabetes;
  • oligomenorrhea or amenorrhea;
  • current treatment with corticosteroids or hormones (oral contraceptives, estrogensic, progestogensin);
  • use of GnRH analogues, SERMs, or SPRMs within the previous 6 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
D-chiro-inositolD-chiro-inositolPatients will take D-chiro-inositol. We will make two blood sampling, at the baseline and after one-month treatment
Primary Outcome Measures
NameTimeMethod
Testosterone30 days

Serum values of testosterone

Secondary Outcome Measures
NameTimeMethod
LH30 days

Serum values of LH

DHEAS30 days

Serum values of DHEAS

FSH30 days

Serum values of FSH

Estradiol30 days

Serum values of estradiol

Glycemia30 days

Serum values of glucose

Insulinemia30 days

Serum values of insulin

BMI30 days

body-mass index

HOMA-IR index30 days

Model of assessment for insulin resistance

Asprosin30 days

Serum values of asprosin

Trial Locations

Locations (2)

ASL Civitavecchia

🇮🇹

Roma, Lazio, Italy

ALMA RES

🇮🇹

Roma, Lazio, Italy

© Copyright 2025. All Rights Reserved by MedPath